Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma.

PLoS One · 2014 · PMC3901680 · PMID 24475086

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

a strong trendp = 0.061so close (0.05 < p ≤ 0.1)

In contrast, in our study we observed no difference in stage IV survival according to the mutational status but a strong trend (p = 0.061) for an impaired DMFS in BRAF mutant patients.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.